MedTrace Logo

Seizures Post Intracerebral Hemorrhage

NCT01115959 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2014-06-12

No results posted yet for this study

Summary

This study examines early antiepileptic treatment with valproic acid for acute cerebral hemorrhage against a placebo group immediately post event to evaluate the outcome of these patients regarding seizures and neurological outcome.

Conditions

  • Post Cerebral Hemorrhage

Interventions

DRUG

valproic acid

treatment of 1 month dosage of 400 mg BID

DRUG

placebo bid

Sponsors & Collaborators

  • Wolfson Medical Center

    lead OTHER_GOV

Principal Investigators

  • ronit gilad, md · E Wolfson med center

  • ronit gilad, md · E wofson med center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-02-28
Primary Completion
2008-10-31
Completion
2008-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01115959 on ClinicalTrials.gov